Dialectical Behavior Therapy for Adolescents at Rutgers University
NCT ID: NCT03861858
Last Updated: 2024-07-30
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
56 participants
INTERVENTIONAL
2019-01-02
2023-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Dialectical Behavior Therapy for Adolescents With Self-harm and Suicidal Behavior- an Open Trial
NCT06315075
Dialectical Behavior Therapy vs Enhanced Usual Care for Suicidal and Self-harming Adolescents. 10 Year Follow-up
NCT04298190
Long Term Efficacy of DBT-A in Adolescents With Repetitive Self-harming and Suicidal Behaviours
NCT01593202
DBT-Based Parenting Intervention for Parents of Youth at Risk for Suicide
NCT04132284
Treatment for Adolescents With Deliberate Self Harm
NCT00675129
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
DBT-A
The standard treatment to be delivered to all participants is DBT-A, which is a treatment model adapted from DBT. DBT-A is an adaptation for adolescents with emotion dysregulation and BPD features (Miller, Rathus, \& Linehan, 2007; Rathus \& Miller, 2015). DBT-A involves weekly individual therapy with the adolescent, weekly multifamily skills group in which adolescents and family members participate, as needed phone coaching, and weekly consultation team for the therapists.
DBT-A
DBT-A is a multimodal therapy which consists of weekly individual therapy, weekly multifamily skills groups, as needed phone coaching, and weekly consultation team for the therapists.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
DBT-A
DBT-A is a multimodal therapy which consists of weekly individual therapy, weekly multifamily skills groups, as needed phone coaching, and weekly consultation team for the therapists.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Agreement of at least one responsible adult parent/caregiver to participate in treatment.
* Agreement to take part in assessments, videotaping/audiotaping and coding of their sessions by research personnel.
* Agreement to pay for mental health services at the DBT- RU on a sliding scale, and to participate in research assessments as volunteers.
* Residence within commuting distance of clinic (\< 45 minutes).
* Agreement to discontinue other forms of talk therapy for duration of DBT program (does not refer to AA/NA programs or psychotropic medication management).
* Exhibits dysregulation within the past six months as evidenced by 1) intentional self-injury and/or suicide attempt and/or 2) substance use disorder.
* Meets two additional criteria for borderline personality disorder (BPD).
Exclusion Criteria
* Non-English speaking.
* IQ \< 70.
* Unable to understand research consent forms.
* Court-ordered to participate in treatment.
13 Years
20 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Rutgers, The State University of New Jersey
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Shireen L. Rizvi, PhD, ABPP
Associate Professor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Rutgers University
Piscataway, New Jersey, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2018001563
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.